First Trust Advisors
CMPX icon

First Trust Advisors’s Compass Therapeutics CMPX Stock Holding History

First Trust Advisors’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
+807,004
New +$2.38M ﹤0.01% 2052

Other funds holding CMPX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

First Trust Advisors's CMPX Position: Q2 2026 in Review

First Trust Advisors opened a new position in Compass Therapeutics (CMPX) in Q2 2026: 807,004 shares worth $1.77M. The stake represents ﹤0.01% of the portfolio and ranks #2052 among its holdings.

86 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • First Trust Advisors held 807,004 shares of Compass Therapeutics worth $1.77M as of Q2 2026.
  • Compass Therapeutics was a new First Trust Advisors position in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2052 holding.
  • 86 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.